BofA lowered the firm’s price target on Zoetis (ZTS) to $205 from $210 and keeps a Buy rating on the shares. Given the company’s significant outside of the U.S. exposure, the firm lowered its FY25-27 revenue forecast to account for a stronger U.S. dollar, the analyst tells investors, adding that the firm keeps a Buy rating on shares based on Zoetis’ “attractive valuation and robust pipeline.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.